You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Guidelines & Advice

About Guidelines Email Guidelines Team

Displaying Guidelines

46 Items

Systemic Therapy for Metastatic Urothelial Cancer: An Endorsement of a Portion of the European Association of Urology Guideline on Muscle-Invasive and Metastatic Bladder Cancer

Document Status: In-Review
ID: GL END 3-24

Aug 2022

Systemic Therapy for Recurrent Epithelial Ovarian Cancer

Document Status: In-Review
ID: 4-3
Version: 4

Jul 2017

Systemic therapy for the treatment of adult patients with lower-risk myelodysplastic syndromes

Document Status: In-Review
ID: 6-13

Mar 2018

Systemic Therapy in Men with Metastatic Castration-Resistant Prostate Cancer: American Society of Clinical Oncology and Cancer Care Ontario Clinical Practice Guideline

Document Status: In-Review
ID: 3-15
Version: 2

Sep 2014

Systemic Treatment of Acute Myeloid Leukemia (AML)

Document Status: In-Review
ID: 12-9

Jan 2016

The Management of Depression in Patients with Cancer

Document Status: In-Review
ID: 19-4

May 2015

The Use of Systemic Treatment in the Maintenance of Patients with Non-Small Cell Lung Cancer

Document Status: In-Review
ID: 7-22

Aug 2015

The Use of Targeted Therapies in Patients with Inoperable Locally Advanced or Metastatic Renal Cell Cancer: Updated Guideline 2017

Document Status: In-Review
ID: 3-8-4
Version: 2

May 2017

Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline

Document Status: In-Review
ID: GL 6-A-2018-1

Mar 2019

Use of the Epidermal Growth Factor Receptor Inhibitors Gefitinib (Iressa®), Erlotinib (Tarceva®), Afatinib, Dacomitinib or Icotinib in the Treatment of Non–SmallCell Lung Cancer: A Clinical Practice Guideline

Document Status: In-Review
ID: 7-9
Version: 2

Apr 2014